Synthases/Synthetase inhibitor, Raltitrexed, Purity ≥98%

Cat. No.: X24-08-YM163

Synthases/Synthetase inhibitor, Raltitrexed, Purity ≥98%

Synonym: 112887-68-0; Tomudex; TDX; ZD 1694; (2S)-2-[[5-[Methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid

  • MDL: MFCD00864168
  • CAS Number: 112887-68-0
  • Compound CID: 135400182
Product Size
10 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Raltitrexed, soluble in DMSO and insoluble in water and ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting synthases/synthetase.
Molecular Weight
458.5
Molecular Formula
C21H22N4O6S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 83 mg/mL (181.02 mM); Water: insoluble; Ethanol: insoluble
Applications
Raltitrexed is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of colorectal cancer.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0